Ireland
--:--IST
Recruiting Observational

Promoting Optimal Treatment Choices in Neonates With Suspected Early-Onset Sepsis

NCT06845332 · tracked via the Priya Life Science Netherlands tracker
Phase
Observational
Started
2024-01-01
Last updated
2025-09-19

Condition(s) studied

Early-onset Sepsis

Study summary

In this study, three neonatal evidence-based antibiotic stewardship strategies will be implemented in Dutch hospitals. These include the early-onset sepsis (EOS) calculator, procalcitonin (PCT)-guided therapy, and IV-to-oral switch therapy. These strategies have been proven to be effective and safe and are already applied in several Dutch hospitals. However, this is not the case for all hospitals, leading to significant variations in clinical practice. To facilitate the translation of evidence into practice, active implementation will take place.

The primary research design is a prospective implementation study, using a multicenter, non-randomized pre-post design. The aim is to assess the impact of implementing a bundle of antibiotic stewardship interventions (including the EOS calculator, PCT-guided therapy and iv-to-oral switch therapy) in Dutch hospitals, using a multicomponent implementation strategy, on both clinical and implementation outcomes, with a particular focus on evaluating the employed implementation strategies.

A combination of qualitative and quantitative research methods will be used to assess outcomes. Quantitative clinical data from neonates in the pre- and post-implementation periods will be retrospectively collected by the Business Intelligence units of participating hospitals and anonymized before being provided to the central research team. Qualitative data will be gathered through focus groups, interviews, and surveys.

Eligibility

Sex
ALL
Min age
—
Max age
3 Days
Healthy volunteers
No
Inclusion Criteria: * Neonates born at 34 weeks of gestation or later * 0-3 days old Exclusion Criteria: * stillborn neonates

Primary outcome measure(s)

  • Days on therapy — 12 months pre-implementation and 12 months post-implementation

Trial sites (11)

FacilityCityRegionStatus
Noordwest Ziekenhuisgroep Alkmaar Netherlands Recruiting
Gelre Ziekenhuis Apeldoorn Netherlands Recruiting
Albert Schweitzer Ziekenhuis Dordrecht Netherlands Recruiting
Catharina Ziekenhuis Eindhoven Netherlands Recruiting
Treant Ziekenhuis Emmen Netherlands Recruiting
Admiraal de Ruyter Ziekenhuis Goes Netherlands Recruiting
Tjongerschans Ziekenhuis Heerenveen Netherlands Recruiting
Zuyderland Medisch Heerlen Netherlands Recruiting
Medisch Centrum Leeuwarden Leeuwarden Netherlands Recruiting
Canisius Wilhelmina Ziekenhuis Nijmegen Netherlands Recruiting
Antonius Ziekenhuis Sneek Sneek Netherlands Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06845332 on ClinicalTrials.gov ↗ ← All trials in the Netherlands